Potential roles of genetic biomarkers in colorectal cancer chemoprevention

Journal of Cellular Biochemistry

Volumn 77, Issue SUPPL. 34, 2000, Pages 28-34

  Syngal, Sapna ^a,b,c   Clarke, Gerard ^b   Bandipalliam, Prathap ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Chemoprevention; Colorectal cancer; Familial adenomatous polyposis; Genetic biomarkers; Hereditary nonpolyposis colorectal cancer; Mutations

Indexed keywords

CANCER GENETICS; CANCER PREVENTION; CANCER RISK; CANCER SCREENING; COLON CARCINOGENESIS; COLORECTAL CANCER; DISEASE ASSOCIATION; FAMILIAL POLYPOSIS; GENETIC MARKER; HUMAN; PRIORITY JOURNAL; REVIEW; CLINICAL TRIAL; COLORECTAL TUMOR; GENETICS; RISK FACTOR;

ANTINEOPLASTIC AGENT; TUMOR MARKER;

ANTICARCINOGENIC AGENTS; CLINICAL TRIALS; COLORECTAL NEOPLASMS; GENETIC MARKERS; HUMANS; RISK FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0033651576     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4644(2000)77:34+<28::AID-JCB7>3.0.CO;2-R     Document Type: Review

References (20)

1. Aarnio M, Sankila R, Pukkala E, Salovaara R, Aaltonen LA, Chapelle ADL, Peltomaki P, Mecklin, Jarvinen HJ. 1999. Cancer risk in mutation carriers of DNA-Mismatch-repair genes. Int J Cancer 81:214-218.
2. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P, Lucibello FC, Murday VA, Rider SH, Scrambler P, et al. 1987. Location of the gene for familial adenomatous polyposis coli on chromosome 5. Nature 328:614-616.
3. Burt RW. 1996. Cohorts with familial disposition for colon cancers in chemoprevention trials. J Cell Biochem Suppl 25:131-135.
4. Crist K, Wang Y, Lubet R, Steele V, Kellof G, Pereira M, Barnes LH, You M. 1995. p53 accumulation and Ki-ras mutations as surrogate endpoint biomarkers (SEBs) for chemoprevention in a rat colon tumor model. Proc Am Assoc Cancer Res 36:591.
5. Crucitti F, Sofo L, Doglietto GB, Belantone R, Ratto C, Bossola M, Crucitti A. 1991. Prognostic factors in colorectal cancer: current status and new trends. J Surg Oncol Suppl 2:76-82.
6. Dhingra K, Vogel V, Sneige N, Sahin A, Aldaz M, Hortobagyi G, Hittelman W. 1993. Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials. J Cell Biochem 17G:37-43.
7. Einspahr J, Alberts D, Gatspur S, Bostick R, Emerson S, Gerner E. 1997. Surrogate end-point biomarkers as measures of colon cancer risk and their use in cancer chemo-prevention trials. Cancer Epidemiol Biomark Prev 6: 37-48.
8. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
9. Friend WG. 1990. Sulindac suppression of colorectal polyps in Gardner's syndrome. Am Fam Physician 41:891-894.
10. Greenwald P, Kelloff GJ, Boone CW, McDonald SS. 1995. Genetic and cellular changes in colorectal cancer: proposed targets of chemopreventive agents. Cancer Epidemiol Biomark Prev 7:691-702.
11. Gryfe R, Swallow C, Bapat B, Redston M, Gallinger S, Couture J. 1997. Molecular biology of colorectal cancer. Curr Probl Cancer 21:233-300.
12. Gryfe R, Di Nicola N, Lal G, Gallinger S, Redston M. 1999. Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism. Am J Hum Genet 64:378-384.
13. Hamilton SR. 1992. The adenoma-adenocarcinoma sequence in the large bowel: variations on a theme. J Cell Biochem Suppl 16G:41-46.
14. Jacobs TW, Prileau JE, Stillman IE, Schnitt SJ. 1996. Loss of tumor marker immunostaining on stored paraffin slides of breast cancer. J Natl Cancer Inst 88:1054-1059.
15. Kelloff G, Boone C, Crowell J, Nayfield S, Hawk E, Malone W, Steele V. 1996. Risk biomarkers and current strategies for cancer chemoprevention. J Cell Biochem Suppl. 25:1-14.
16. Kelloff GJ, Hawk ET, Karp JE, Crowell JA, Boone CW, Steele VE, Lubet R, Sigman CC. 1997. Progress in clinical chemoprevention. Semin Oncol 24:241-252.
17. Kopreski MS, Benko FA, Kwee C, Leitzel KE, Eskander E, Lipton A, Gocke CD. 1997. Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer. Br J Cancer 76:1293-1299.
18. Krishnan K, Ruffin MT, Brenner DE. 1998. Clinical models of chemoprevention for colon cancer. Hematol Oncol Clin North Am 12:1079-1113.
19. Laken SJ, Petersen GM, Gruber SB, Oddoux C, Ostrer H, Giardiello FM, Hamilton SR, Hampel H, Markowitz A, Klimstra D, et al. 1997. Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC. Nature Genet 17:79-83.
20. Landis SH, Murray T, Bolden S, Wingo PA. 1999. Cancer Statistics, 1999. CA Cancer J Clin 49(1):8-31.